Study of the genetic factors predisposing to the development of psoriasis

Abstract


Many findings confirm the influence of neuropsychic factors on the manifestation and exacerbation of the atopic dermatitis and psoriasis. Nowadays it is assumed that by means of neurotransmitters’ secretion the nervous system can influence different processes, including the immune mediated inflammation, which has the key role in the pathogenesis of such dermatosis. The article hereunder contains comprehensive data on prospective trends of following studies of the nervous regulation participation in the pathogenesis of such dermatosis.

Full Text

Изучение генетических факторов предрасположенности к развитию псориаза

References

  1. Tausk F., Elenkov I., Moynihan J. Psychoneuroimmunology Therapy, Vol. 21, 2008, 22-31.
  2. Arck P.C., Slominski A., Theoharides T.C. et al. Neuroimmunology of Stress: Skin Takes Center Stage Journal of Investigative Dermatology (2006) 126, 1697-1704.
  3. Смулевич А.Б., Львов А.Н., Иванов О.Л. Патомимии. Психопатология аутоагрессии в дерматологической практике. М: МИА; 160.
  4. Миченко A.B., Львов A.H. Атопический дерматит: аспекты психосоматических расстройств. Обзор литературы. Consilium medicum. Псих. расстройства в общей медицине. 2008; 1: 47-52.
  5. Joseph T., Kurian J., Warwick D.J. et al. Unilateral remission of psoriasis following traumatic nerve palsy. Br J Dermatol 2005; 152: 185-6.
  6. Troilius A, Möller H. Unilateral eruption of endogenous eczema after hemiparesis. Аcta Derm Venereol 1989; 69 (3): 256-8.
  7. Roosterman D., Tobias G., Schneider S.W. et al. Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ Physiol Rev 2006; 86: 1309-1379.
  8. Zegarska B., Lelinska A., Tyrakowski T. Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacological Reports 2006; 58, 13-21.
  9. Peters E.M., Ericson M.E., Hosoi J. et al. Neuropeptide Control Mechanisms in Cutaneus Biology: Physiological and Clinical Significance. J of Investigative Dermatology 2006; 126: 1937-1947.
  10. Misery L., Bourchanny D., Kanitakis J. et al. Modulation of substance P and somatostatin receptors in cutaneous lymphocytic inflammatory and tumoral infiltrates. J Eur Acad Dermatol Venereol 2001; May; 15 (3): 238-41.
  11. Ramez M., Bagot M., Nikolova M. et al. Functional Characterization of Neurotensin Receptors in Human Cutaneous T Cell Lymphoma Malignant Lymphocytes. J Invest Dermatol 2001; 117: 687-693.
  12. Magazin M., Poszepczynska-Guigne E., Bagot M. et al. Sezary Syndrome Cells Unlike Normal Circulating T Lymphocytes Fail to Migrate Following Engagement of NT1 Receptor J Invest Dermatol 2004; 122: 111-118.
  13. Altawil R., Lystrom J., El-Nour H. Kinetics of neuronal contribution during the development of a contact allergic reaction. Arch Dermatol Res 2012; May; 304 (4): 273-81.
  14. Aubdool A.A., Brain S.D. Neurovascular aspects of skin neurogenic inflammation. J Investig Dermatol Symp Proc 2011 Dec; 15 (1): 33-9.
  15. Jarvikallio A., Harvima I.T., Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; Apr; 295 (1): 2-7.
  16. Maintz L., Wardelmann E., Walgenbach K. et al. Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis. Allergy 2011; Jul; 66 (7): 862-9.
  17. Орлова Е.А., Молотилов Б.А Нейропептиды и «нейрогенное воспаление» в патогнезе крапивницы. Практическая медицина. 2012; 51: 98-103.
  18. Cetin E.D., Savk E., Uslu M. et al. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 2009 Feb; 31 (1): 53-60.
  19. Lima E.A., Lima M.A. Reviewing concepts in the immunopathogenesis of psoriasis. An Bras Dermatol 2011; 86 (6): 1151-8.
  20. Новицкая Н.Н., Якубович А.И. Качество жизни и псориаз: психологические аспекты Сиб. мед. журн. 2008; 2: 8-13.
  21. Panconesi E, Hautmann G. Psychophysiology of stress in dermatology. The psychobiologic pattern of psychosomatics. Dermatol Clin 1996; 14: 399-421.
  22. Бутов Ю.С., Конокова Е.П. Кожный зуд. Лечащий врач. 2003; 4: 24-26.
  23. Metz M., Grundmann S., Stander S. Pruritus: an overview of current concepts. Vet Dermatol 2011; Apr; 22 (2): 121-31.
  24. Buddenkotte J., Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 2010; 65: 805-821.
  25. Nakamura M., Toyoda M., Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol 2003; Oct: 149(4): 718-30.
  26. Chang S.E., Han S.S., Jung H.J. et al. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 2007 Jun;156 (6): 1272-7.
  27. Jarvicallio A., Harvima I.T., Naukkarien A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; 295: 2-7.
  28. Salomon J., Baran E. The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol 2008; 22: 223-228.
  29. Toyoda M., Nakamura M., Makino T. et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147: 71-72.
  30. Hodeib A., El-Samad Z.A., Hanafy H. et al. Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis. Indian J Dermatol 2010; 55: 135-139.
  31. Taneda K., Tominaga M., Negi O. et al. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol. 2011 Aug; 165 (2): 277-84.
  32. Tominagа M., Takamori K. Mechanisms Regulating Epidermal Innervation in Pruritus of Atopic Dermatitis Skin Biopsy - Perspectives 157-182.
  33. Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol 2000; 10: 85-90.
  34. Dou Y.C., Hagstromer L., Emtestam L. et al. Increased nerve growth factor and its receptors in atopic dermatitis: an immuno- histochemical study. Arch Dermatol Res 2006; 298: 31-7.
  35. Takaoka K., Shirai Y., Saito N. Inflammatory Cytokine Tumor Necrosis Factor-а Enhances Nerve Growth Factor Production in Human Keratinocytes, HaCaT Cells. J Pharmacol Sci 2009; 111: 381-391.
  36. Kakurai M., Monteforte R., Suto H. et al. Mast Cell-Derived Tumor Necrosis Factor Can Promote Nerve Fiber Elongation in the Skin during Contact Hypersensitivity in Mice. Am J Pathol 2006 Nov; 169 (5): 1713-21.
  37. Kato K., Kikuchi S., Shubayev VI. et al. Distribution and tumor necrosis factor-alpha isoform binding specificity of locally administered etanercept into injured and uninjured rat sciatic nerve. Neuroscience 2009 May 5; 160 (2): 492-500.
  38. Aloe L., Alleva E., Fiore M. Stress and nerve growth factor: findings in animal models and humans. Pharmacol Biochem Behav 2002; 73 (1): 159-166.
  39. Raychaudhuri SP, Farber EM, Raychaudhuri SK. Role of nerve growth factor in RANTES expression by keratinocytes. Acta Derm Venereol 2000 Jul-Aug; 80 (4): 247-50.
  40. Turrini P., Gaetano C., Antonelli A. et al. Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett 2002; 323: 102-12.
  41. Moser K.V., Reindl M., Blasig I. et al. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation. Brain Res 2004; 1017: 53-60.
  42. Forsythe J.A., Jiang B.H., Iyer N.V. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996 Sep; 16 (9): 4604-13.
  43. Saban M.R., Davis C.A., Avelino A. et al. VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG. BMC Physiology 2011, 11: 16.
  44. Nakamura K., Tan F., Li Z. et al. NGF Activation of TrkA Induces Vascular Endothelial Growth Factor Expression via induction of Hypoxia-Inducible Factor-1α Mol Cell Neurosci. 2011 February; 46 (2): 498-506.
  45. Schonthaler H.B., Huggenberger R., Wculek S.K. et al. Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci USA. 2009 Dec 15; 106 (50): 21264-9.
  46. Raychaudhuri S.P., Jiang W.Y., Raychaudhuri S.K. Role of NGF and Its Receptor System in the Pathogenesis of Psoriasis. Am J Pathol 2008 Apr; 172 (4): 961-71.
  47. Raychaudhuri S.P., Sanyal M., Weltman H. et al. K252a, a High-Affinity Nerve Growth Factor Receptor Blocker,Improves Psoriasis: An In Vivo Study Using the Severe Combined Immunodeficient Mouse-Human Skin Model. J Invest Dermatol 2004; 122: 812-819.
  48. Masahiko T. Useful therapeutic markers of atopic dermatitis: neurogenic factors. Skin Research 2005; 4 (Suppl 5): 87-93.
  49. Yamaguchi J, Aihara M, Kobayashi Y et al. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 2009; 53: 48-54.
  50. Cook P.W., Brown J.R., Cornell K.A. et al. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp Dermatol 2004 13: 347-56.
  51. Nilsson A., Kanje M. Amphiregulin acts as an autocrine survival factor for adult sensory neurons. Neuroreport 200516: 213-8.
  52. Takahashi H., Tsuji H., Hashimoto Y. Cell proliferation and cytokine induction by TNF а of psoriatic keratinocytes are not different from normal keratinocytes in vitro Indian J Dermatol 2009 Jul; 54 (3): 237-9.
  53. Fujisawa H. Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. J Neurobiol 2004 59: 24-33.
  54. Negi O., Tominaga M., Tengara S. et al. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis. J Dermatol Sci 2012 Apr; 66 (1): 37-43.
  55. Tordjman R., Lepelletier Y., Lemarchandel V. et al. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 2002; 3: 477-82.
  56. Lepelletier Y., Moura I.C., Hadj-Slimane R. et al. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol 2006; 36: 1782-93.
  57. Kou K., Nakamura F., Aihara M. et al. Decreased Expression of Semaphorin-3A, a Neurite-Collapsing Factor, is Associated With Itch in Psoriatic Skin. Acta Derm Venereol. 2012 May; 8.
  58. Kurschat P., Bielenberg D., Rossignol-Tallandier M. et al. Neuron restrictive silencer factor NRSF/ REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J Biol Chem 2006; 281: 2721-2729.
  59. Tominaga M., Tengara S., Kamo A. et al. Psoralenultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci 2009 55: 40-6.
  60. Shepherd A.J., Beresford L.J., Bell E.B. et al. Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P. J Neuroimmunol 2005 Jul; 164 (1-2): 115-23.
  61. Bost K.L., Breeding S.A., Pascual D.W. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. Reg Immunol 1992; 4: 105-112.
  62. Freidin M., Kessler J.A. Cytokine regulation of substance P expression in sympathetic neurons. Proc Natl Acad Sci USA 1991; 88: 3200-3203.
  63. Steinhoff M., Stander S., Seeliger S. et al. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 2003; 139: 1479-1488.
  64. Black P.H. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immunol 2002; 10: 1-32.
  65. Campos M.M., Calixto J.B. Neurokinin mediation of edema and inflammation. Neuropeptides 2000; 34: 314-322.
  66. Saraceno R., Kleyn C.E., Terenghi G. et al. The role of neuropeptides in psoriasis. BJD 2006; 154: 876-882.
  67. Lotti T., Bianchi B., Panconesi E. Neuropeptides and skin disorders. The new frontiers of neuroendocrine-cutaneous immunology. Int J Dermatol 1999; 38: 673-675.
  68. Pavlovich S., Daniltchenko M., Tobin D.J. et al. Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 2008; 128: 434-446.
  69. Stander S., Siepmann D., Herrgott I. et al. Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy. PLoS ONE 2010; 5(6): e10968.
  70. Lee JH, Cho SH. Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatitis model. J Ethnopharmacol 2011 Jan; 27: 133 (2): 810-7.
  71. He Y., Ding G., Wang X. et al. Calcitonin generelated peptide in Langerhans cells in psoriatic plaque lesions. Chinese Medical Jornal 2000; 113: 8: 747-751.
  72. Yu X.J., Li C.Y., Xu Y.H. et al. Calcitonin generelated peptide increases proliferation of human HaCaT keratinocytes by activation of MAP kinases. Cell Biol Int 2009; Nov: 33 (11): 1144-8.
  73. Wallengren J., Sundler F. Phototherapy Reduces the Number of Epidermal and CGRP-positive Dermal Nerve Fibres. Acta Derm Venereol 2004; 84: 111-115.

Statistics

Views

Abstract - 538

PDF (Russian) - 387

PlumX

Article Metrics

Metrics Loading ...

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2012 LVOV A.N., KATUNINA O.R., ZNAMENSKAYA L.F., MICHENKO A.V., EGOROVA Y.Y., INOYATOVA L.A., HAIRULLIN R.F., VOLKOV I.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies